Asters Advises the EBRD on EUR 15 Mln Financing for the Ukrainian Pharmaceutical Company Yuria-Pharm

March 20, 2025

Featured partners

Share

The loan will be used to finance the company’s investment plans in Ukraine and Uzbekistan. In Ukraine, the company plans to certify its production with the European Union (EU) Good Manufacturing Practice standard, install solar panels and carry out critical IT upgrades. In Uzbekistan, the loan will help to expand the production facilities, install solar panels and improve energy efficiency.

HIGHLIGHTS

Related News

Log in